Lv1
40 积分 2025-01-03 加入
Dissecting the clinicopathological, genomic, and prognostic significance of ALK rearrangement in resected lung adenocarcinoma
2天前
已完结
Lung cancer treatment compromised by delayed genomic test results
2天前
已完结
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
2天前
已完结
Effect of ground-glass opacity components on the recurrence of pathological stage IB non-small cell lung cancer harboring epidermal growth factor receptor mutations
2天前
已关闭
Systematic Literature Review and Trial-Level Meta-Analysis of Aromatase Inhibitors vs Tamoxifen in Patients With HR+/HER2− Early Breast Cancer
7天前
已关闭
Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysis
7天前
已关闭
Dynamic ctDNA informs whole-course postoperative precise management of NSCLC (LUNGCA study)
11天前
已完结
Brief Report: The Effectiveness of Osimertinib in Advanced Non-small Cell Lung Cancer Harboring Various EGFR Exon 19 Mutation Variants
23天前
已完结
Immunotherapy in advanced non-small cell lung cancer: What to do for the ‘Invisible’ patients after IPSOS trial results?
24天前
已完结
Longitudinal Analysis of Recurrence and Risk Factors of Early-stage Resected Adenocarcinoma with Common EGFR Mutations: A Multicenter Retrospective Cohort Study in South Korea
29天前
已关闭
皖公网安备34019202002308
